SORAFENIB PLUS TEGAFUR–URACIL (UFT) VERSUS SORAFENIB AS FIRST LINE SYSTEMIC TREATMENT FOR PATIENTS WITH ADVANCED STAGE HCC: A PHASE II TRIAL (ESLC01 STUDY)

Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)

Hamdy A Azim,1 Ashraf Omar,2 Hesham Atef,1,† Heba Zawahry,3 Mohamed K Shaker,4 AH Kamel Abdelmaksoud,5 Mohamed EzzElarab,6 Omar Abdel-Rahman,7 Mohamed Ismail,8 Loay Kassem,1 Imam Waked9 1Department of Clinical Oncology, Faculty of Medicine, Cairo University, Cairo, Egypt; 2Department of Gastroenterology, Faculty of Medicine, Cairo University

read more



Balanced labellings of affine permutations

We study the $ extit{diagrams}$ of affine permutations and their $ extit{balanced}$ labellings.As in the finite case, Personal Care Kits which was investigated by Fomin, Greene, Reiner, and Shimozono, the balanced labellings give a natural encoding of reduced decompositions of affine permutations.In fact, we show that the sum of weight monomials of

read more